|
|
| | 2-[(2-Chloro-4-nitrophenoxy)methyl]pyridine Basic information |
| Product Name: | 2-[(2-Chloro-4-nitrophenoxy)methyl]pyridine | | Synonyms: | 3-Chloro-4-(2-pyridinylmethoxy)-1-nitrobenzene;2-[(2-Chloro-4-nitrophenoxy)methyl]pyridine;Pyridine, 2-[(2-chloro-4-nitrophenoxy)methyl]-;Neratinib Impurity 35;2-((4-chloro-3-nitrophenoxy)methyl)pyridine | | CAS: | 179687-79-7 | | MF: | C12H9ClN2O3 | | MW: | 264.66 | | EINECS: | 605-865-3 | | Product Categories: | | | Mol File: | 179687-79-7.mol | ![2-[(2-Chloro-4-nitrophenoxy)methyl]pyridine Structure](CAS/GIF/179687-79-7.gif) |
| | 2-[(2-Chloro-4-nitrophenoxy)methyl]pyridine Chemical Properties |
| storage temp. | Inert atmosphere,Room Temperature | | Appearance | Light brown to brown Powder |
| | 2-[(2-Chloro-4-nitrophenoxy)methyl]pyridine Usage And Synthesis |
| Uses | 3-Chloro-4-(2-pyridylmethyloxy)nitrobenzene was used to synthesize aniline ''headgroups'' and incorporat them into an alkynyl thienopyrimidine series of EGFR and ErbB-2 inhibitors. | | Synthesis | General procedure for the synthesis of 2-((2-chloro-4-nitrophenoxy)methyl)pyridine from 2-chloro-4-nitrophenol and 2-chloromethylpyridine hydrochloride: 2-chloromethylpyridine hydrochloride (16.4 g, 0.1 mol) and potassium carbonate (K2CO3, 27.6 g, 0.2 mol) were suspended in N,N-dimethylformamide (DMF, 100 mL). stirred for 30 min at room temperature. Subsequently, 2-chloro-4-nitrophenol (17.4 g, 0.1 mol) and potassium iodide (KI, 0.83 g, 5 mol%) were added, and the reaction mixture was stirred for 12 hours at 60 °C. After completion of the reaction, the reaction mixture was diluted with water (400 mL), the resulting solid was collected by filtration, washed with water and dried to afford 2-((2-chloro-4-nitrophenoxy)methyl)pyridine (26 g, 98% yield) as a white solid. The melting point of the product was 149.2-149.9 °C; mass spectra (MS-EI) m/z: 92, 229, 263 (M+). | | References | [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 11, p. 3090 - 3104
[2] Patent: US2016/214964, 2016, A1. Location in patent: Paragraph 0138
[3] Patent: WO2005/10008, 2005, A1. Location in patent: Page/Page column 114-115
[4] Patent: WO2006/23843, 2006, A2. Location in patent: Page/Page column 64
[5] Patent: US2010/298297, 2010, A1. Location in patent: Page/Page column 14 |
| | 2-[(2-Chloro-4-nitrophenoxy)methyl]pyridine Preparation Products And Raw materials |
|